Login / Signup

In silico exploration of venlafaxine, a potential non-tricyclic antidepressant in a liposomal formulation for nose-to-brain drug delivery.

Sulekha KhuteRajendra K Jangde
Published in: Drug development and industrial pharmacy (2023)
The results present that VLF-LPs formulation is a promising potential platform for application in nose-to-brain drug delivery. Thus, highlighting the robustness of the intranasal drug delivery system with enhanced pharmaceutical properties, efficacy and bioavailability for the Anti-depression effect.
Keyphrases